SPIRONOLACTONE IN DERMATOLOGICAL THERAPY

被引：62

作者：

SHAW, JC

机构：

[1] OREGON HLTH SCI UNIV, DEPT AGR CHEM, PORTLAND, OR 97201 USA

[2] GOOD SAMARITAN HOSP, DIV DERMATOL, PORTLAND, OR 97210 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1991年 / 24卷 / 02期

关键词：

D O I：

10.1016/0190-9622(91)70034-Y

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

In the treatment of androgen-mediated skin disorders spironolactone provides a valuable therapeutic option. This article reviews the use of spironolactone as an antiandrogen in dermatologic therapy. The endocrinologic effects, pharmacology, dermatologic uses, and side effects are discussed, and guidelines for its use are provided.

引用

页码：236 / 243

页数：8

共 69 条

[61] AGRANULOCYTOSIS CAUSED BY SPIRONOLACTONE [J].

STRICKER, BHC ;

OEI, TT .

BRITISH MEDICAL JOURNAL, 1984, 289 (6447) :731-731

[62] EFFECT OF SPIRONOLACTONE ON SEX-HORMONES IN MAN [J].

STRIPP, B ;

TAYLOR, AA ;

BARTTER, FC ;

GILLETTE, JR ;

LORIAUX, DL ;

EASLEY, R ;

MENARD, RH .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 41 (04) :777-781

[63] ENDOCRINE EFFECTS OF SPIRONOLACTONE IN MAN [J].

TIDD, MJ ;

HORTH, CE ;

RAMSAY, LE ;

SHELTON, JR ;

PALMER, RF .

CLINICAL ENDOCRINOLOGY, 1978, 9 (05) :389-399

[64]

VELLACOTT ID, 1987, J REPROD MED, V32, P429

[65]

WATHEN CG, 1986, LANCET, V1, P919

[66]

WEINER IM, 1985, PHARMACOL BASIS, P900

[67] ANTIANDROGENIC EFFECTS OF TOPICALLY APPLIED SPIRONOLACTONE ON THE HAMSTER FLANK ORGAN [J].

WEISSMANN, A ;

BOWDEN, J ;

FRANK, BL ;

HORWITZ, SN ;

FROST, P .

ARCHIVES OF DERMATOLOGY, 1985, 121 (01) :57-62

[68]

YLOSTALO P, 1987, INT J FERTIL, V32, P41

[69]

YOUNG RL, 1987, FERTIL STERIL, V48, P223

← 1 2 3 4 5 6 7 →